News and Events

Join Anna Kapeliukha and Mariana Perebyinis at the 24th European Symposium on Quantitative Structure-Activity Relationship in Barcelona, September 22-26! 

We are excited to announce an update that simplifies your ordering process!

We are summarizing the latest updates from Chemspace! Check out our August posts!

We at Chemspace are committed to providing the chemical building blocks to fulfill the needs of your projects. Start your research with us!

Here is a fresh update in Meet Chemspace Team series! We are excited to introduce our Office Manager – Ruslana Yehorova.

Vorasidenib, also known by the brand name VORANIGO®, is a first-in-class oral dual inhibitor targeting mutant IDH1 and IDH2, which slows the growth and progression of gliomas.

Buy a Primary Antibody, Get a Secondary Antibody as a Compliment! You can choose any primary antibody, even a sample size - no restrictions.

Chemspace is constantly creating new screening compound sets to stay at the forefront of drug discovery. Download and explore the new set here.

Hello from the CPHI 2024 in Korea! Dr. Olena Mishchuk is excited to catch up with participants and explore potential collaborations. If you are attending and want to connect, do not hesitate to reach out to Olena.

Join Rita Gaidar, Uliana Matvienko, and Anna Kapeliukha at the EFMC-ISMC 2024 in Rome, from 1st – 5th September! To schedule a one-on-one meeting, contact us at [email protected].

Check out the latest Chemspace co-authored article - 'The Freedom Space – a new set of commercially available molecules for hit discovery'.

Did you know that RNAs, the key carriers of genetic information, play a crucial role in the progression of diseases like HIV, diabetes, cancer, and more? Consider the potential of targeting RNA structures to create innovative new treatments. 

Our colleagues Dr. Olena Mishchuk, Director of Business Development, Asia Pacific Region, and Dr. Iaroslava Kos, Director of Business Development at Enamine, will be available at the CPHI Korea conference from August 27-29 in Seoul.

Compounds containing 1,3-Benzodioxole are known for inhibiting the COX enzyme and cytotoxic effects against cancer cells such as cervical cells. Check out our selection of 1,3-Benzodioxole-based building blocks to enhance your research.

Do not miss out — order today and take your projects to the next level!

Have you been missing our #MeetChemspaceTeam post series? Say hello to our Account Manager – Viktor Korniienko! Click the link to discover more about him.

Tulmimetostat is a selective and orally bioavailable Enhancer of Zeste Homolog 2 (EZH2) inhibitor, that demonstrates promising potential in treating hematologic malignancies and solid tumors. Discover a set of analogs for Tulmimetostat to expand further research.

Did you miss any of our July news and highlights? Here is a comprehensive summary of our posts for this month!

Explore a selected Biological Products Set from Chemspace for studying Orexin receptors, which is pivotal in treating major depressive disorder and insomnia. Follow the link to check out the comprehensive selection at Chemspace Biologics!

Great news! All our flyers, posters & press releases are now in one place. Check them out and download the latest materials.

The latest issue of the "Building Blocks for Drug Candidates" series! Discover analogs to a core of Fosigotifator, a promising treatment for Amyotrophic Lateral Sclerosis  - a rare and fatal neurological condition.

Hot News for the Hot Season! From now on all special offers are in one place! Do not wait - follow the link and discover all the terms and conditions.

Meet Halyna Hrodziuk – our Account Manager! Follow the link to learn about Halyna closer. 

Ifebemtinib – a highly selective, orally bioavailable FAK (focal adhesion kinase) inhibitor discovered by Boehringer Ingelheim and developed by InxMed, shows significant potential as a cancer therapy. Follow the link to explore a set of analogs from Chemspace.

Here is a summary of all Chemspace news and highlights for June, in case you missed it.